share_log

《大行報告》高盛上調三葉草生物-B(02197.HK)目標價至3.37元 評級「中性」

AASTOCKS ·  Dec 20, 2022 10:15

三葉草生物-B(02197.HK)完成配售1.28億股,相當於公司經擴大後股本約9.91%,淨籌約5億元。高盛發表報告,上調三葉草生物今年及明年淨利潤預測各0.9%和0.6%,後年則下調0.7%,以反映淨現金的變化。以經風險調整現金流折現率計,目標價由3.26元上升至3.37元, 評級「中性」。

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment